BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34446941)

  • 21. Hereditary Medullary Thyroid Cancer Genotype-Phenotype Correlation.
    Frank-Raue K; Raue F
    Recent Results Cancer Res; 2015; 204():139-56. PubMed ID: 26494387
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Orolabial signs are important clues for diagnosis of the rare endocrine syndrome MEN 2B. Presentation of two unrelated cases.
    Sallai A; Hosszú E; Gergics P; Rácz K; Fekete G
    Eur J Pediatr; 2008 Apr; 167(4):441-6. PubMed ID: 17576593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple endocrine neoplasia-IIb with RET gene mutation p.M918T: A case report.
    Jin P; Hu W; Yang Y; Long X; Mo Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 45(10):1261-1265. PubMed ID: 33268590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple endocrine neoplasia 2B syndrome due to codon 918 mutation: clinical manifestation and course in early and late onset disease.
    Brauckhoff M; Gimm O; Weiss CL; Ukkat J; Sekulla C; Brauckhoff K; Thanh PN; Dralle H
    World J Surg; 2004 Dec; 28(12):1305-11. PubMed ID: 15517484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased in vivo phosphorylation of ret tyrosine 1062 is a potential pathogenetic mechanism of multiple endocrine neoplasia type 2B.
    Salvatore D; Melillo RM; Monaco C; Visconti R; Fenzi G; Vecchio G; Fusco A; Santoro M
    Cancer Res; 2001 Feb; 61(4):1426-31. PubMed ID: 11245446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOS1 frameshift mutations cause pure mucosal neuroma syndrome, a clinical phenotype distinct from multiple endocrine neoplasia type 2B.
    Owens M; Kivuva E; Quinn A; Brennan P; Caswell R; Lango Allen H; Vaidya B; Ellard S
    Clin Endocrinol (Oxf); 2016 May; 84(5):715-9. PubMed ID: 26708403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple Endocrine Neoplasia Type 2B Presents Early in Childhood but Often Is Undiagnosed for Years.
    Makri A; Akshintala S; Derse-Anthony C; Widemann B; Stratakis CA; Glod J; Lodish M
    J Pediatr; 2018 Dec; 203():447-449. PubMed ID: 30314660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hereditary medullary thyroid carcinoma syndromes: experience from western India.
    Diwaker C; Sarathi V; Jaiswal SK; Shah R; Deshmukh A; Thomas AE; Prakash G; Malhotra G; Patil V; Lila A; Shah N; Bandgar T
    Fam Cancer; 2021 Jul; 20(3):241-251. PubMed ID: 33392850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple endocrine neoplasia 2B: delayed presentation, rapid diagnosis.
    Balachandran K; Kamalanathan S; Gopalakrishnan S; Murugananadham K
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
    Fox E; Widemann BC; Chuk MK; Marcus L; Aikin A; Whitcomb PO; Merino MJ; Lodish M; Dombi E; Steinberg SM; Wells SA; Balis FM
    Clin Cancer Res; 2013 Aug; 19(15):4239-48. PubMed ID: 23766359
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of the 918 mutation in the RET proto-oncogene in a Mexican patient with multiple endocrine neoplasia type 2B.
    Hidalgo A; Medrano ME; Rodrìguez S; Franco C; Martinez I; Benítez L; Salcedo M
    J Exp Clin Cancer Res; 1998 Jun; 17(2):149-52. PubMed ID: 9700574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management.
    Raue F; Frank-Raue K
    Hormones (Athens); 2009; 8(1):23-8. PubMed ID: 19269918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Late diagnosis of metastatic pheochromocytoma in multiple endocrine neoplasia 2B with rapid clinical decline.
    Jester G; Hassanein H; El-Far A
    BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33541961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Girl with Delayed Puberty and Bumpy Lips.
    Andrade S; Sirchia F; Faleschini E; Barbi E
    J Pediatr; 2018 Dec; 203():454-454.e1. PubMed ID: 30025668
    [No Abstract]   [Full Text] [Related]  

  • 35. [Multiple endocrine neoplasia type 2B].
    Pijnenburg-Kleizen KJ; van Santen HM; Koolen DA; Claahsen-van der Grinten HL
    Ned Tijdschr Geneeskd; 2015; 159():A7719. PubMed ID: 25944066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laryngeal Ganglioneuromatosis in a Child With Multiple Endocrine Neoplasia Type 2B (MEN2B): Case Report and Review of Literature.
    Chornenkyy Y; Than J; Ghadersohi S; Melin-Aldana H; Chou P
    Cureus; 2024 Mar; 16(3):e55406. PubMed ID: 38562350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of gene expression induced by RET with MEN2A or MEN2B mutation.
    Watanabe T; Ichihara M; Hashimoto M; Shimono K; Shimoyama Y; Nagasaka T; Murakumo Y; Murakami H; Sugiura H; Iwata H; Ishiguro N; Takahashi M
    Am J Pathol; 2002 Jul; 161(1):249-56. PubMed ID: 12107109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medullary thyroid carcinoma in children.
    Viola D; Romei C; Elisei R
    Endocr Dev; 2014; 26():202-13. PubMed ID: 25231454
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcriptome analysis in mouse tumors induced by Ret-MEN2/FMTC mutations reveals subtype-specific role in survival and interference with immune surveillance.
    Engelmann D; Koczan D; Ricken P; Rimpler U; Pahnke J; Li Z; Pützer BM
    Endocr Relat Cancer; 2009 Mar; 16(1):211-24. PubMed ID: 18984779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RET activation by germline MEN2A and MEN2B mutations.
    Borrello MG; Smith DP; Pasini B; Bongarzone I; Greco A; Lorenzo MJ; Arighi E; Miranda C; Eng C; Alberti L
    Oncogene; 1995 Dec; 11(11):2419-27. PubMed ID: 8570194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.